Document Detail

Pharmacokinetic analysis of enterohepatic circulation of 4-[2-(4-isopropylbenzamido)ethoxy]benzoic acid. Effect of intramolecular rearrangement of its acyl glucuronide.
MedLine Citation:
PMID:  1356739     Owner:  NLM     Status:  MEDLINE    
The enterohepatic circulation of 4-[2-(4-isopropylbenzamido)ethoxy]benzoic acid (PBAB) was studied in rats after an iv administration of 30 mg/kg. After the bolus injection, the PBAB concentrations in the plasma decreased rapidly, then increased to a peak concentration at 4 hr. Over a 6-hr period, 52% of the dose (Fe) was excreted in the bile as 1 beta-O-acyl glucuronide of PBAB (1 beta-PG). Elimination of PBAB from the plasma of bile duct-cannulated rats was more rapid than for the sham-operated rats. These results suggest that PBAB undergoes enterohepatic circulation. The equation for an enterohepatic circulation model was fitted to the plasma PBAB concentrations for intact rats using the program MULTI (FILT) to estimate the single circulating fraction (Fc) (bile----intestine----systemic circulation). The Fc value was 0.072, which means that 7.2% of the dose was reabsorbed to systemic circulation during the first cycle. The fraction (Fa) reabsorbed from small intestine to systemic circulation during first cycle can be estimated by the formula Fa = Fo/Fa. The Fa value obtained was 14% of the dose, which was smaller than the Fa' (26% of the dose) standing for systemic availability of PBAB after oral dosing. When 1 beta-PG was incubated with bile for 2 hr, 79% was transformed to beta-glucuronidase-resistant isomers by intramolecular acyl migration. We consider that the acyl migration of 1 beta-PG in the small intestine or bile causes the difference between Fa and Fa' values, and decreases the enterohepatic circulation of PBAB.
H Komura; H Fukui; H Sasaki; A Morino
Related Documents :
4000979 - Uptake mechanism of interstitially injected 99mtc-labeled antimony trisulphide colloid ...
3718589 - Metabolic fate of the new cardiotonic denopamine in animals. 2nd communication: tissue ...
10222009 - Intrinsic erythrocyte labeling and attomole pharmacokinetic tracing of 14c-labeled foli...
18581409 - Quantification of choline- and ethanolamine-containing metabolites in human prostate ti...
8858839 - Quantitative urinary excretion of unmetabolised n tau-[me-14c] methylhistidine by the c...
17569689 - Natural radioactivity levels and radiation hazard indices in granite from aswan to wadi...
6690169 - Mephenytoin hydroxylation deficiency: kinetics after repeated doses.
21232109 - A scavenging double mask to reduce workplace contamination during mask induction of inh...
8349939 - Relative potencies and time course of changes in adenosine 5'-monophosphate airway resp...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Drug metabolism and disposition: the biological fate of chemicals     Volume:  20     ISSN:  0090-9556     ISO Abbreviation:  Drug Metab. Dispos.     Publication Date:    1992 Jul-Aug
Date Detail:
Created Date:  1992-11-13     Completed Date:  1992-11-13     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  9421550     Medline TA:  Drug Metab Dispos     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  585-91     Citation Subset:  IM    
Pharmacy Laboratories, Nippon Shinyaku Co., Ltd., Kyoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Benzoates / pharmacokinetics*
Benzoic Acids*
Enterohepatic Circulation*
Glucuronates / metabolism*
Intestinal Absorption
Rats, Inbred Strains
Reg. No./Substance:
0/Benzoates; 0/Benzoic Acids; 0/Glucuronates; 113079-40-6/4-(2-(4-isopropylbenzamido)ethoxy)benzoic acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  3'-azido-3'-deoxythymidine drug interactions. Screening for inhibitors in human liver microsomes.
Next Document:  Pharmacokinetics and tissue distribution of human urinary tumor necrosis factor binding protein in m...